Whole Blood Point of Care Metabolic Measurement

家长资助：HD 107897 PA-21-345长期研究者管理补充 项目摘要 Sequitur Health Corp.正在为美国国立卫生研究院（National Institutes of Health Phase II Small Business）进行研究。 创新研究（SBIR）家长补助金：HD 107897，用于开发一个用于测量 分析物直接从一滴全血。Sequitur系统具有>90%的测量精度， 与美国食品药品监督管理局批准的临床实验室仪器方法相比， 测量该分析物。 Sequitur Health Corp.是一家由女性拥有的小企业，部分由一名来自美国的女性拥有。 社会弱势群体，由美国小企业协会（美国SBA）定义。 Sequitur将使用此补充聘请博士-西班牙裔女性，来自社会弱势群体， 根据美国SBA的定义。该长期研究者将协助完成母公司 第二阶段SBIR奖正在进行的研究目标。这一行政补充的直接影响将是 增加美国小企业劳动力的多样性。这一政策的长期影响 补充将帮助个人雇用贡献正在进行的研究，发展更多的技能， 作为一名有着远大理想的独立科学家开始了成功的职业生涯。

Parent Grant: HD107897 PA-21-345 Administrative Supplement for Long-Term Investigator Project Summary Sequitur Health Corp. is performing research for a National Institutes of Health Phase II Small Business Innovation Research (SBIR) Parent Grant: HD107897 to develop a point of care system for measurement of an analyte directly from a drop of whole blood. The Sequitur system has >90% accuracy for measurement of this analyte compared to the U.S. Food and Drug Administration approved clinical laboratory instrument method for measuring this analyte. Sequitur Health Corp. is a women-owned small business that is partially owned by a female from a socially disadvantaged group, as defined by the United States Small Business Association (U.S. SBA). Sequitur will use this supplement to hire a Ph.D.-level Hispanic female, who is from a socially disadvantaged group as defined by the U.S. SBA. This Long-Term Investigator will contribute to the completion of the parent Phase II SBIR award ongoing research Aims. The immediate impact of this administrative supplement will be to increase diversity in the United States Small Business workforce. The long-term impact of this administrative supplement will be to help the individual hired contribute to the ongoing research, develop more skills, and launch a successful career as an entrepreneurial-minded independent scientist.